Browsing: CBD

Roxana Gonzalez /Shutterstock

Casara Andre is stuck between a rock and a hard place. In fact, so are all of her clients and some of her colleagues. The owner of Scheduled Relief veterinary clinic and a practicing veterinarian, Andre thinks cannabis products have medical benefits for pets, but she can’t legally recommend cannabis for her furry patients, and there’s little published research on the benefits of cannabis for animals to support her beliefs.

Lindsey Bartlett

On July 20, the Senate Appropriations Committee approved the Energy and Water Development appropriations bill for fiscal year 2018, authorizing $38.4 billion in spending. Wedged into this bill was the Industrial Hemp Water Rights Act, a piece of bipartisan legislation introduced in part by Colorado senators Michael Bennet and Cory Gardner.

Thinkstock.com

Days after a letter from Attorney General Jeff Sessions surfaced, asking congressional leaders to revoke federal protections for medical marijuana, senators have introduced a bill that would protect medical marijuana patients in states where it’s legal while also removing cannabidiol (CBD) from the Controlled Substances Act and expanding research on marijuana.
Senators Cory Booker (D-New Jersey), Mike Lee (R-Utah), Kirsten Gillibrand (D-New York), Rand Paul (R-Kentucky), Al Franken (D-Minnesota) and Lisa Murkowski (R-Arkansas) introduced the Compassionate Access Research and Respect the States (CARERS) Act on June 15. The bill would protect medical marijuana users from federal prosecution, allow Department of Veterans Affairs doctors to recommend medical marijuana to veterans, and loosen multiple restrictions on cannabis research and medical compounds.

14875946061_3caae2a9f4_o_1_Brett Levin

The Drug Enforcement Administration (DEA) could be facing a lawsuit after its announcement earlier this week that it now considers cannabidiol, or CBD, a Schedule I substance.

The DEA doesn’t have the authority to make a law and schedule controlled substances without an act of Congress, argues Robert Hoban, managing partner at the Hoban Law Group. The Denver firm has represented various hemp and marijuana businesses since 2008, many of which have told Hoban and his partners that they would be plaintiffs in a lawsuit.

Bubble_gum_at_the_Haribo_factory-MartialBACQUET.jpg
MartialBacquet/commons, edited by TokeoftheTown.com.

A New York and Netherlands-based biotechnology company focusing on medical cannabis research says they plan to start making pot-infused bubblegum in the Netherlands that they plan to sell internationally.
Axim Biotechnologies, which already makes a product called CanChew that contains CBD, say they will manufacture CanChew and a new product, MedChew, which will contain THC. Officials with the company tell in-PharmaTechnologist.com they are already conducting clinical trials on patients with Multiple Sclerosis as well as inflammatory bowel problems and Crohn’s disease in Amsterdam.

1 2 3